Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |